




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
AntiinfectiveagentsChapters37,38,39&41Antibiotics:DefinitionMedicationsusedtotreatbacterialinfectionsIdeally,beforebeginningantibiotictherapy,thesuspectedareasofinfectionshouldbeculturedtoidentifythecausativeorganismandpotentialantibioticsusceptibilitiesAntibiotics:ClassesSulfonamides
Penicillins CephalosporinsTetracyclinesMacrolidesAminoglycosidesQuinolonesFigure37-1Bacterialmorphologies.(FromMurray,P.R.,Rosenthal,K.S.,Kobayashi,G.S.,&Pfaller,M.A.(2002).Medicalmicrobiology.St.Louis,MO:Mosby.)Figure37-3Gram-stainmorphologyofbacteria.ThecrystalvioletofGramstainisprecipitatedbyGramiodineandistrappedinthethickpeptidoglycanlayeringram-positivebacteria.Thedecolorizerdispersesthegram-negativeoutermembraneandwashesthecrystalvioletfromthethinlayerofpeptidoglycan.Gram-negativebacteriaarevisualizedbytheredcounterstain.(FromMurray,P.R.,Rosenthal,K.S.,Kobayashi,G.S.,&Pfaller,M.A.(2002).Medicalmicrobiology.St.Louis,MO:Mosby.)Figure37-4Gram-positiveandgram-negativebacteria.Agram-positivebacteriumhasathicklayerofpeptidoglycan
(left).Agram-negativebacteriumhasathinpeptidoglycanlayerandanoutermembrane(right).Structuresinparenthesesarenotfoundinallbacteria.(FromMurray,P.R.,Rosenthal,K.S.,Kobayashi,G.S.,&Pfaller,M.A.(2002).Medicalmicrobiology.St.Louis,MO:Mosby.)AntibioticTherapyEmpirictherapy:treatmentofaninfectionbeforespecificcultureinformationhasbeenreportedorobtainedProphylactictherapy:treatmentwithantibioticstopreventaninfection,asinintraabdominalsurgeryAntibioticTherapy(cont’d)TherapeuticresponseDecreaseinspecificsignsandsymptomsofinfectionarenoted(fever,elevatedWBC,redness,inflammation,drainage,pain)SubtherapeuticresponseSignsandsymptomsofinfectiondonotimproveAntibioticTherapy(cont’d)FourcommonmechanismsofactionInterferencewithcellwallsynthesisInterferencewithproteinsynthesisInterferencewithDNAreplicationActingasametabolitetodisruptcriticalmetabolicreactionsinsidethebacterialcellActionsofAntibioticsBactericidal:killbacteriaBacteriostatic:inhibitgrowthofsusceptiblebacteria,ratherthankillingthemimmediately;willeventuallyleadtobacterialdeathAntibiotics:SulfonamidesOneofthefirstgroupsofantibioticssulfadiazineSulfamethoxazole(Bactrim)sulfisoxazoleSulfonamides:
MechanismofActionBacteriostaticactionPreventsynthesisoffolicacidrequiredforsynthesisofpurinesandnucleicacidDonotaffecthumancellsorcertainbacteria—theycanusepreformedfolicacidSulfonamides:IndicationsTreatmentofUTIscausedbysusceptiblestrainsof:Enterobacterspp.,
Escherichiacoli,Klebsiellaspp.,Proteusmirabilis,Proteusvulgaris,StaphylococcusaureusNocardiosisPneumocystiscariniipneumonia(PCP)UpperrespiratorytractinfectionsOtherusesSulfonamides:
CombinationProductstrimethoprim/sulfamethoxazoleUsedtotreatUTIs,PCP,otitismedia,otherconditionserythromycin/sulfisoxazoleUsedtotreatotitismediasulfisoxazoleUsedtotreatotitismedia,UTIs,otherconditionsBeta-LactamAntibioticsPenicillinsCephalosporinsCarbapenemsMonobactamsPenicillinsNaturalpenicillinsPenicillinase-resistantpenicillinsAminopenicillinsExtended-spectrumpenicillinsPenicillins(cont’d)NaturalpenicillinspenicillinG,penicillinVpotassiumPenicillinase-resistantpenicillinsCloxacillinAminopenicillinsamoxicillin,ampicillin,pivamicillinAnti-pseudomonalpenicillins
piperacillinsodium
Penicillins(cont’d)Firstintroducedinthe1940sBactericidal:inhibitcellwallsynthesisKillawidevarietyofbacteriaAlsocalled“beta-lactams”Penicillins(cont’d)BacteriaproduceenzymescapableofdestroyingpenicillinsTheseenzymesareknownas
beta-lactamasesAsaresult,themedicationisnoteffectivePenicillins(cont’d)Chemicalshavebeendevelopedtoinhibittheseenzymes:Clavulanicacid(Clavulin)TazobactamSulbactamThesechemicalsbindwithbeta-lactamaseandpreventtheenzymefrombreakingdownthepenicillinPenicillins:
MechanismofActionPenicillinsenterthebacteriaviathecellwallInsidethecelltheybindtopenicillin-bindingproteinOncebound,normalcellwallsynthesisisdisruptedResult:bacteriacellsdiefromcelllysisPenicillinsdonotkillothercellsinthebodyPenicillins:IndicationsPreventionandtreatmentofinfectionscausedbysusceptiblebacteria,suchas:Gram-positivebacteriaStreptococcus,Enterococcus,Staphylococcus
spp.Penicillins:AdverseEffectsAllergicreactionsoccurin0.7%to8%ofcasesUrticaria,pruritus,angioedema10%ofallergicreactionsarelifethreatening10%ofthesearefatalPenicillins:SideEffectsCommonsideeffectsNausea,vomiting,diarrhea,abdominalpainOthersideeffectsarelesscommonCephalosporinsFirstgenerationSecondgenerationThirdgenerationFourthgenerationCephalosporins(cont’d)SemisyntheticderivativesfromafungusStructurallyandpharmacologicallyrelatedtopenicillinsBactericidalactionBroadspectrumDividedintogroupsaccordingtotheirantimicrobialactivityCephalosporins:FirstGeneration
cephalexin(Keflex)
cefazolin(Ancef)
cefadroxil(Duricef)Goodgram-positivecoveragePoorgram-negativecoverageCephalosporins:
FirstGeneration(cont’d)Usedforsurgicalprophylaxis,URIs,otitismediacefazoline:IVorPO(Ancef)cephalexin:PO(Keflex)Cephalosporins:
SecondGenerationGoodgram-positivecoverageBettergram-negativecoveragethanfirstgenerationcefaclorcefprozilcefoxitincefuroximecefotetan
Cephalosporins:
SecondGeneration(cont’d)cefoxitin:IVandIMUsedprophylacticallyforabdominalorcolorectalsurgeriesAlsokillsanaerobescefuroxime:POSurgicalprophylaxisDoesnotkillanaerobesCephalosporins:
ThirdGenerationMostpotentgroupagainstgram-negativeLessactiveagainstgram-positivecefiximecefotaximeceftizoximeceftriaxoneceftazidimeCephalosporins:
ThirdGeneration(cont’d)cefiximeOnlyoralthird-generationagentBestofavailableoralcephalosporinsagainstgram-negativeTabletandsuspensionceftriaxoneIVandIM,longhalf-life,once-a-dayadministrationEasilypassesmeningesanddiffusedintoCSFtotreatCNSinfectionsCephalosporins:
FourthGenerationcefepimeNewestcephalosporinagentsBroaderspectrumofantibacterialactivitythanthirdgeneration,especiallyagainstgram-positivebacteriaCephalosporins:SideEffectsSimilartopenicillinsMacrolideserythromycinazithromycinclarithromycinMacrolides:
MechanismofActionPreventproteinsynthesiswithinbacterialcellsBacteriawilleventuallydieMacrolides:IndicationsStrepinfectionsStreptococcuspyogenes
(groupAbeta-hemolyticstreptococci)MildtomoderateURIHaemophilusinfluenzaeSpirochetalinfectionsSyphilisandLymediseaseGonorrhea,Chlamydia,MycoplasmaMacrolides:SideEffectsGIeffects,primarilywitherythromycinNausea,vomiting,diarrhea,hepatotoxicity,flatulence,jaundice,anorexiaNeweragents,azithromycinandclarithromycin:fewersideeffects,longerdurationofaction,betterefficacy,bettertissuepenetrationTetracyclinesdemeclocyclineoxytetracyclinetetracyclinedoxycyclineminocyclineTetracyclines(cont’d)NaturalandsemisyntheticObtainedfromculturesofStreptomycesBacteriostatic—inhibitbacterialgrowthInhibitproteinsynthesisStopmanyessentialfunctionsofthebacteriaTetracyclines(cont’d)BindtoCa2+andMg2+andAl3+ionstoforminsolublecomplexesThus,dairyproducts,antacids,andiron
saltsreduceabsorptionoftetracyclinesTetracyclines:IndicationsWidespectrumGram-negative,gram-positive,protozoa,Mycoplasma,Rickettsia,Chlamydia,syphilis,LymediseasedemeclocyclineisalsousedtotreatSIADH,andpleuralandpericardialeffusionsTetracyclines:SideEffectsStrongaffinityforcalciumDiscolorationofpermanentteethandtoothenamelinfetusesandchildrenMayretardfetalskeletaldevelopmentiftakenduringpregnancyTetracyclines:SideEffects(cont’d)Alterationinintestinalfloramayresultin:Superinfection(overgrowthofnonsusceptibleorganismssuchasCandida)DiarrheaPseudomembranouscolitisTetracyclines:SideEffects(cont’d)Mayalsocause:VaginalmoniliasisGastricupsetEnterocolitisMaculopapularrashAminoglycosidesgentamicinneomycinstreptomycintobramycinamikacinAminoglycosides(cont’d)NaturalandsemisyntheticProducedfromStreptomycesPoororalabsorption;noPOformsPotentantibioticswithserioustoxicitiesBactericidal;preventsproteinsynthesisKillmostlygram-negative;some
gram-positivealsoAminoglycosides:IndicationsUsedtokillgram-negativebacteriasuchasPseudomonas
spp.,E.coli,Proteus
spp.,Klebsiellaspp.,Serratiaspp.OftenusedincombinationwithotherantibioticsforsynergisticeffectAminoglycosides:
Indications(cont’d)AllaminoglycosidesarepoorlyabsorbedthroughtheGItract,andgivenparenterallyException:neomycinGivenorallytodecontaminatetheGItractbeforesurgicalproceduresAlsousedasanenemaforthispurposeAminoglycosides:AgentsThreemostcommon(systemic):gentamicin,tobramycin,amikacinCauseserioustoxicitiesNephrotoxicity(renalfailure)Ototoxicity(auditoryimpairmentandvestibular[eighthcranialnerve])MustmonitordruglevelstopreventtoxicitiesAminoglycosides:SideEffectsOtotoxicityandnephrotoxicityarethemostsignificantHeadacheParesthesiaNeuromuscularblockadeDizziness
VertigoSkinrashFeverSuperinfectionsQuinolonesciprofloxacinnorfloxacinofloxacinlevofloxacingatifloxacinQuinolones(cont’d)ExcellentoralabsorptionAbsorptionreducedbyantacidsFirstoralantibioticseffectiveagainst
gram-negativebacteriaQuinolones:
MechanismofActionBactericidalEffectiveagainstgram-negativeorganismsandsomegram-positiveorganismsAlterDNAofbacteria,causingdeathDonotaffecthumanDNAQuinolones:IndicationsLowerrespiratorytractinfectionsBoneandjointinfectionsInfectiousdiarrheaUrinarytractinfectionsSkininfectionsSexuallytransmitteddiseasesAnthraxQuinolones:IndicationsLowerrespiratorytractinfectionsBoneandjointinfectionsInfectiousdiarrheaUrinarytractinfectionsSkininfectionsSexuallytransmitteddiseasesAnthraxQuinolones:SideEffectsBodySystem
EffectsCNS Headache,dizziness, fatigue, depression,restlessnessGI Nausea,vomiting, diarrhea,constipation, thrush, increasedliverfunction studiesQuinolones:SideEffects(cont’d)BodySystem
EffectsIntegumentary Rash,pruritus,urticaria, flushing,photosensitivity (withlomefloxacin)Other Fever,chills,blurred vision, tinnitusOtherAntibioticsclindamycin(MRSA)Metronidazole(anaerobes)nitrofurantoin(uncomplicatedUTI)OtherAntibiotics(cont’d)vancomycinNatural,bactericidalantibioticDestroyscellwallTreatmentofchoiceforMRSA,andothergram-positiveinfectionsMustmonitorbloodlevelstoensuretherapeuticlevelsandpreventtoxicityMaycauseototoxicityandnephrotoxicityOtherAntibiotics(cont’d)vancomycin(cont’d)Shouldbeinfusedover60minutesMonitorIVsitecloselyRedman’ssyndromemayoccurDecreasedBP,flushingofneckandfaceAntihistaminemaybeorderedtoreducetheseeffectsEnsureadequatehydration(2Lfluids/ 24hr)ifnotcontraindicatedtopreventnephrotoxicityAntibiotics:NursingImplicationsBeforebeginningtherapy,assessdrugallergies;hepatic,liver,andcardiacfunction;andotherlabstudiesBesuretoobtainthoroughclienthealthhistory,includingimmunestatusAssessforconditionsthatmaybecontraindicationstoantibioticuseorthatmayindicatecautioususeAssessforpotentialdruginteractionsNursingImplicationsItisrecommendedtoobtainculturesfromappropriatesitesBEFOREbeginningantibiotictherapyNursingImplications(cont’d)Clientsshouldbeinstructedtotakeantibioticsexactlyasprescribedandforthelengthoftimeprescribed;theyshouldnotstoptakingthemedicationearlywhentheyfeelbetterAssessforsignsandsymptomsofsuperinfection:fever,perinealitching,cough,lethargy,oranyunusualdischargeNursingImplications(cont’d)Forsafetyreasons,checkthenameofthemedicationcarefullybecausetherearemanyagentsthatsoundalikeorhavesimilarspellingsNursingImplications(cont’d)EachclassofantibioticshasspecificsideeffectsanddruginteractionsthatmustbecarefullyassessedandmonitoredThemostcommonsideeffectsofantibioticsarenausea,vomiting,anddiarrheaAlloralantibioticsareabsorbedbetteriftakenwithatleast180to240mLofwaterNursingImplications(cont’d)EachclassofantibioticshasspecificsideeffectsanddruginteractionsthatmustbecarefullyassessedandmonitoredThemostcommonsideeffectsofantibioticsarenausea,vomiting,anddiarrheaAlloralantibioticsareabsorbedbetteriftakenwithatleast180to240mLofwaterNursingImplications(cont’d)EachclassofantibioticshasspecificsideeffectsanddruginteractionsthatmustbecarefullyassessedandmonitoredThemostcommonsideeffectsofantibioticsarenausea,vomiting,anddiarrheaAlloralantibioticsareabsorbedbetteriftakenwithatleast180to240mLofwaterNursingImplications(cont’d)SulfonamidesShouldbetakenwithatleast2000mLoffluidperday,unlesscontraindicatedDuetophotosensitivity,avoidsunlightand
tanningbedsTheseagentsreducetheeffectivenessof
oralcontraceptivesOralformsshouldbetakenwithfoodormilktoreduceGIupsetNursingImplications(cont’d)PenicillinsAnyclienttakingapenicillinshouldbecarefullymonitoredforanallergicreactionforatleast30minutesafteritsadministrationTheeffectivenessoforalpenicillinsisdecreasedwhentakenwithcaffeine,citrusfruit,colabeverages,fruitjuices,ortomatojuiceNursingImplications(cont’d)CephalosporinsOrallyadministeredformsshouldbegivenwithfoodtodecreaseGIupset,eventhoughthiswilldelayabsorptionSomeoftheseagentsmaycauseadisulfiram-likereactionwhentakenwithalcoholNursingImplications(cont’d)MacrolidesTheseagentsarehighlyprotein-boundandwillcausesevereinteractionswithotherprotein-bounddrugsTheabsorptionoforalerythromycinisenhancedwhentakenonanemptystomach,butbecauseofthehighincidenceofGIupset,manyagentsaretakenafteramealorsnackNursingImplications(cont’d)TetracyclinesMilkproducts,ironpreparations,antacids,andotherdairyproductsshouldbeavoidedbecauseofthechelationanddrug-bindingthatoccursAllmedicationsshouldbetakenwith180to240mLoffluid,preferablywaterDuetophotosensitivity,avoidsunlightand
tanningbedsNursingImplications(cont’d)AminoglycosidesMonitorpeakandtroughbloodlevelsoftheseagentstopreventnephrotoxicityandototoxicitySymptomsofototoxicityincludedizziness,tinnitus,andhearinglossSymptomsofnephrotoxicityincludeurinarycasts,proteinuria,andincreasedBUNandserumcreatininelevelsNursingImplications(cont’d)QuinolonesShouldbetakenwithatleast3Loffluidperday,unlessotherwisespecifiedIntakeofalkalinefoodsanddrugs,suchasantacids,dairyproducts,peanuts,andsodiumbicarbonateshouldbelimited UnderstandingVirusesViralreplicationAviruscannotreplicateonitsownItmustattachtoandenterahostcellItthenusesthehostcell’senergytosynthesizeprotein,DNA,andRNAFigure38-1Virusreplication.Somevirusesintegrateintohostchromosomeswithdevelopmentoflatency.(ModifiedfromBrody,T.M.,Larner,J.,&Minneman,K.P.(1998).Humanpharmacology:moleculartoclinical(3rded.).St.Louis,MO:Mosby.)UnderstandingViruses(cont’d)Virusesaredifficulttokillbecausetheyliveinsidehumancells Anydrugthatkillsavirusmayalsokill humancellsViralInfectionsCompetentimmunesystem:BestresponsetoviralinfectionsAwell-functioningimmunesystemwilleliminateoreffectivelydestroyvirusreplication
ViralInfections(cont’d)Immunocompromisedclientshavefrequentviralinfections Cancerclients,especiallyleukemiaor lymphoma Transplantclients,duetopharmacological therapy AIDSclients,diseaseattacksimmunesystemAntiviralsViruseskilledbycurrentantiviraltherapyCytomegalovirus(CMV)HepatitisvirusesHerpesvirusesHumanimmunodeficiencyvirus(HIV)Influenzaviruses(the“flu”)Respiratorysyncytialvirus(RSV) Antivirals(cont’d)KeycharacteristicsofantiviraldrugsAbletoenterthecellsinfectedwithvirusInterferewithviralnucleicacidsynthesisand/orregulationSomeagentsinterferewithabilityofvirus
tobindtocellsSomeagentsstimulatethebody’simmunesystemAntiviralMedicationsAntiviralagentsUsedtotreatinfectionscausedbyvirusesotherthanHIVAntiretroviralagentsUsedtotreatinfectionscausedbyHIV,thevirusthatcausesAIDSAntiviralAgents:NonretroviralMechanismofactionInhibitviralreplicationUsedtotreatnon-HIVviralinfectionsInfluenzavirusesHSV,VZV(anotherherpesvirus)CMVHepatitisA,B,C(HAV,HBV,HCV)HIVHumanimmunodeficiencyvirusinfectionELISA(enzyme-linkedimmunosorbentassay)DetectsHIVexposurebasedonpresenceofhumanantibodiestothevirusinthebloodRetrovirusTransmittedby:Sexualactivity,intravenousdruguse,perinatallyfrommothertochildNaturalHistoryofHIVInfectionPrimaryacuteinfectionAsymptomaticinfectionEarlysymptomaticinfectionAdvancedimmunodeficiencywithopportunisticcomplicationsOpportunisticInfectionsProtozoalToxoplasmosisofthebrain,othersFungalCandidiasisofthelungs,esophagus,tracheaPCP,othersViralCMVdisease,HSVinfection,othersOpportunisticInfections(cont’d)BacterialVariousmycobacterialinfections,othersOpportunisticneoplasiasKaposi’ssarcoma,othersOthersAntiretroviralAgents(cont’d)Reversetranscriptaseinhibitors(RTIs)Blockactivityoftheenzymereversetranscriptase,preventingproductionofnewviralDNAProteaseinhibitors(PIs)Inhibittheproteaseretroviralenzyme,preventingviralreplicationFusioninhibitorsInhibitviralfusion,preventingviralreplicationAntiretroviralAgents:
SideEffectsNumerousandvarywitheachagentDrugtherapymayneedtobemodifiedbecauseofsideeffectsGoalistofindtheregimenthatwillbestcontroltheinfectionwithatolerablesideeffectprofileMedicationregimenschangeduringthecourseoftheillnessAntivirals:NursingImplicationsBeforebeginningtherapy,thoroughly
assessunderlyingdiseaseandmedicalhistory,includingallergiesAssessbaselineVSandnutritionalstatusAssessforcontraindications,conditions
thatmayindicatecautioususe,andpotentialdruginteractionsNursingImplicationsBesuretoteachproperapplicationtechniqueforointments,aerosolpowders,etc.EmphasizehandwashingbeforeandafteradministrationofmedicationstopreventsitecontaminationandspreadofinfectionClientsshouldwearagloveorfingercotwhenapplyingointmentsorsolutionstoaffectedareasNursingImplications(cont’d)Instructclientstoconsulttheirphysicianbeforetakinganyothermedication,includingOTCsEmphasizetheimportanceofgoodhygieneInformclientsthatantiviralagentsarenotcuresbutdohelptomanagesymptomsNursingImplications(cont’d)InstructclientsontheimportanceoftakingthesemedicationsexactlyasprescribedandforthefullcourseoftreatmentMonitorforsideeffectsEffectsarevariedandspecifictoeachagentNursingImplications(cont’d)MonitorfortherapeuticeffectsEffectswillvarydependingonthetypeofviralinfectionEffectsrangefromdelayedprogressionofAIDSandARCtodecreaseinflulikesymptoms,decreasedfrequencyofherpes-likeflare-ups,orcrustingoverofherpeticlesionsAntituberculousAgentsTuberculosis(TB)CausedbyMycobacteriumtuberculosisAntituberculousagentstreatallformsofMycobacteriumTuberculosisTuberculosis(abbreviatedasTBforTubercleBacillusisacommonanddeadlyinfectiousdiseasecausedbythemycobacteriumtuberculosisSymptomsincludeaproductive,prolongedcoughofmorethanthreeweeksduration,chestpain,andcoughingupblood.Systemicsymptomsincludefever,chills,nightsweats,appetiteloss,weightloss,paling,andthoseafflictedareofteneasilyfatiguedMycobacteriumInfectionsCommoninfectionsitesLung(primarysite)BrainBoneLiverKidneyMycobacteriumInfections(cont’d)AerobicbacillusPassedfrominfected:HumansCows(bovine)Birds(avian)MycobacteriumInfections(cont’d)TuberclebacilliareconveyedbydropletsDropletsareexpelledbycoughingorsneezing,thengainentryintothebodybyinhalationTuberclebacillithenspreadtootherbodyorgansviabloodandlymphaticsystemsTuberclebacillimaybecomedormant,orwalledoffbycalcifiedorfibroustissueAntituberculousAgentsFirst-LineAgentsisoniazid*INHethambutolpyrazinamide(PZA)rifampinstreptomycin*MostfrequentlyusedSecond-LineAgentscapreomycincycloserineethionamidekanamycinpara-aminosalicyclicacid(PAS)MechanismofActionThreegroupsProteinwallsynthesisinhibitors(streptomycin,kanamycin,capreomycin,rifampin,rifabutin)Cellwallsynthesisinhibitors(cycloserine,ethionamide,isoniazid)OthermechanismsofactionIsoniazid(INH)DrugofchoiceforTBResistantstrainsofMycobacteriumemergingMetabolizedintheliverthroughacetylation—watchfor“slowacetylators”UsedaloneorincombinationwithotheragentsIndicationsUsedfortheprophylaxisortreatmentofTBAntituberculousTherapyEffectivenessdependsupon:TypeofinfectionAdequatedosingSufficientdurationoftreatmentDrugcomplianceSelectionofaneffectivedrugcombinationAntituberculousTherapy(cont’d)ProblemsDrug-resistantorganismsDrugtoxicityClientnoncomplianceSideEffectsINH
–Peripheralneuritis,hepatotoxicityEthambutol
–Retrobulbarneuritis,blindnessRifampin
–Hepatitis,discolorationofurine,stoolsNursingImplicationsObtainathoroughmedicalhistoryandassessmentPerformliverfunctionstudiesinclients
whoaretoreceiveisoniazidorrifampin
(especiallyinelderlyclientsorthosewhousealcoholdaily)Assessforcontraindicationstothevariousagents,conditionsforcautioususe,andpotentialdruginteractionsNursingImplications(cont’d)ClienteducationiscriticalTherapymaylastforupto24monthsTakemedicationsexactlyasordered,
atthesametimeeverydayEmphasizetheimportanceofstrictcompliancetoregimenforimprovementofconditionorcureNursingImplications(cont’d)Clienteducationiscritical(cont’d)Remindclientsthattheyarecontagiousduringtheinitialperiodoftheirillness—instructinproperhygieneandpreventionofthespreadofinfecteddropletsEmphasizetoclientstotakecareofthemselves,includingadequatenutritionandrestNursingImplications(cont’d)Clientsshouldnotconsumealcoholwhileonthesemedicationsortakeothermedications,includingOTC,unlesstheycheckwiththeirphysicianDiabeticclientstakingINHshouldmonitorbloodglucoselevelsbecausehyperglycemiamayoccurINHandrifampincauseoralcontraceptivestobecomeineffective;anotherformofbirthcontrolwillbeneededNursingImplications(cont’d)Clientswhoaretakingrifampinshouldbetoldthattheirurine,stool,saliva,sputum,sweat,ortearsmaybecomereddishorange;evencontactlensesmaybestainedPyridoxinemaybeneededtocombatneurologicsideeffectsassociatedwithINHtherapyOralpreparationsmaybegivenwithmealstoreduceGIupset,eventhoughrecommendationsaretotakethem1hourbeforeor2hoursaftermealsNursingImplications(cont’d)MonitorforsideeffectsInstructclientsonthesideeffectsthatshouldbereportedtothephysicianimmediatelyTheseincludefatigue,nausea,vomiting,numbnessandtinglingoftheextremities,fever,lossofappetite,depression,jaundiceNursingImplications(cont’d)MonitorfortherapeuticeffectsDecreaseinsymptomsofTB,suchascough
andfeverLaboratorystudies(cultureandsensitivitytests)andCXRshouldconfirmclinicalfindingsWatchforlackofclinicalresponsetotherapy,indicatingpossibledrugresistanceAntifungalAgents:DefinitionDrugsusedtotreatinfectionscausedbyfungi Systemic TopicalFungiLargeanddiversegroupofmicro-organismsBrokendownintoyeastsandmouldsFungalinfectionsalsoknownasmycosisSomefungiarepartofthenormalfloraoftheskin,mouth,intestines,vaginaYeastsSingle-cellfungiReproducebybuddingCanbeusedforBakingAlcoholicbeveragesMouldsMulticellularCharacterizedbylong,branchingfilamentscalledhyphaeMycoticInfectionsFourgeneraltypesCutaneousSubcutaneousSuperficial,mostSystemic**Canbelifethreatening*UsuallyoccurinimmunocompromisedhostMycoticInfections(cont’d)CandidaalbicansDuetoantibiotictherapy,antineoplastics,orimmunosuppressants(corticosteroids)MayresultinovergrowthandsystemicinfectionsInthemouthOralcandidiasisorthrushNewborninfantsandimmunocompromisedclientsVaginalcandidiasis“Yeastinfection”Pregnancy,diabetesmellitus,oralcontraceptivesAntifungalAgentsSystemicamphotericinB,fluconazole,ketoconazole,itraconazoleTopicalExamples:clotrimazole,miconazole,nystatinIndicationsSystemicandtopicalfungalinfectionsAgentofchoiceforthetreatmentofmanyseveresystemicfungalinfectionsisamphotericinBChoiceofagentdependsontypeandlocationofinfectionSideEffects:AmphotericinBFeverHeadache Malaise Hypotension MuscleandjointpainLoweredpotassiumlevels
Mainconcerns:RenaltoxicityNeurotoxicity:seizuresandparesthesiasChills
Dysrhythmias
NauseaAnorexia“Shakeandbake”AntifungalAgents:
SideEffects(cont’d)FluconazoleNausea,vomiting,diarrhea,stomachpainIncreasedliverfunctionstudiesGriseofulvinRash,urticaria,headache,nausea,vomiting,anorexia,othersNursingImplicationsFollowmanufacturer’sdirectionscarefullyforreconstitutionandadministrationMonit
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年光電子器件及激光器件合作協(xié)議書
- 脊髓髓內(nèi)腫瘤治療
- 肺結(jié)核上報流程
- 腦外科引流管護(hù)理常規(guī)
- 一年級數(shù)學(xué)計算題專項練習(xí)匯編
- 二年級數(shù)學(xué)計算題專項練習(xí)
- 2025年無功功率自動補(bǔ)償裝置合作協(xié)議書
- 四年級下冊音樂教案-第一單元《憶江南》人教新課標(biāo)(2014秋)
- 人教版(PEP)五年級下冊英語期末測試卷(三)(含答案 無聽力試題)
- 幼兒園買食品注意安全
- 2024年貴州現(xiàn)代物流產(chǎn)業(yè)集團(tuán)有限公司招聘筆試參考題庫含答案解析
- 20222023八下語文提優(yōu)輔導(dǎo)02(教師+學(xué)生)
- 共和國史(自己整理-僅供參考)
- 視頻監(jiān)控維保項目投標(biāo)方案(技術(shù)標(biāo))
- 涉農(nóng)(農(nóng)、林、水)地方標(biāo)準(zhǔn)宣貫推廣實施方案(試行)
- NB-T 11076-2023 高壓交流故障電流限制器通用技術(shù)規(guī)范
- 整縣(市、區(qū))屋頂分布式光伏開發(fā)方案書-V5
- 透水磚鋪裝施工方案
- 《十步訊問法》讀書筆記
- GB/T 42599-2023風(fēng)能發(fā)電系統(tǒng)電氣仿真模型驗證
- 質(zhì)量問題解決方法之7鉆流程法
評論
0/150
提交評論